Literature DB >> 10998522

The nociceptin (ORL1) receptor: molecular cloning and functional architecture.

J Meunier1, L Mouledous, C M Topham.   

Abstract

Nociceptin and the ORL1 receptor share high sequence similarity with opioid peptides, particularly dynorphin A, and their receptors. However, nociceptin and dynorphin A may use distinct molecular pathways to bind and activate their cognate receptors. Activation of the kappa-opioid receptor by dynorphin A is thought to require interactions of its N-terminal hydrophobic domain (Y(1)GGF) with the receptor opioid binding pocket, located within the transmembrane helix bundle, while activation of the ORL1 receptor appears to require interactions of the positively charged core (R(8)KSARK) of nociceptin with the negatively charged second extracellular receptor loop.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10998522     DOI: 10.1016/s0196-9781(00)00225-4

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  11 in total

1.  Molecular modelling studies on the ORL1-receptor and ORL1-agonists.

Authors:  Britta M Bröer; Marion Gurrath; Hans-Dieter Höltje
Journal:  J Comput Aided Mol Des       Date:  2003-11       Impact factor: 3.686

2.  Study on the activation of the opioid receptors by a set of morphine derivatives in a well-defined assay system.

Authors:  Yan Zhang; Zhiwei Wang; D Phillip Cox; Olivier Civelli
Journal:  Neurochem Res       Date:  2011-10-16       Impact factor: 3.996

3.  Bradycardia elicited by microinjections of nociceptin/orphanin FQ into the intermediolateral cell column at T1-T2 in the rat.

Authors:  Vineet C Chitravanshi; Hreday N Sapru
Journal:  Neurosci Lett       Date:  2007-02-07       Impact factor: 3.046

4.  Effect of novel nociceptin/orphanin FQ-NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats.

Authors:  D Economidou; A Fedeli; R Martin Fardon; F Weiss; M Massi; R Ciccocioppo
Journal:  Peptides       Date:  2006-12       Impact factor: 3.750

Review 5.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

6.  Minocycline enhances the effectiveness of nociceptin/orphanin FQ during neuropathic pain.

Authors:  Katarzyna Popiolek-Barczyk; Ewelina Rojewska; Agnieszka M Jurga; Wioletta Makuch; Ferenz Zador; Anna Borsodi; Anna Piotrowska; Barbara Przewlocka; Joanna Mika
Journal:  Biomed Res Int       Date:  2014-09-03       Impact factor: 3.411

7.  Probing ligand recognition of the opioid pan antagonist AT-076 at nociceptin, kappa, mu, and delta opioid receptors through structure-activity relationships.

Authors:  V Blair Journigan; Willma E Polgar; Edward W Tuan; James Lu; Pankaj R Daga; Nurulain T Zaveri
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

8.  Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2.

Authors:  Salvatore Pacifico; Federica Ferrari; Valentina Albanese; Erika Marzola; Joaquim Azevedo Neto; Chiara Ruzza; Girolamo Calò; Delia Preti; Remo Guerrini
Journal:  J Med Chem       Date:  2020-09-24       Impact factor: 7.446

Review 9.  Post-triptan era for the treatment of acute migraine.

Authors:  Peter J Goadsby
Journal:  Curr Pain Headache Rep       Date:  2004-10

Review 10.  Inhibitory Gi/O-coupled receptors in somatosensory neurons: Potential therapeutic targets for novel analgesics.

Authors:  Yevgen Yudin; Tibor Rohacs
Journal:  Mol Pain       Date:  2018 Jan-Dec       Impact factor: 3.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.